Pharma Sources Insight April 2023: Innovative Drugs Going Abroad

How to Subscribe?

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world. 

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and medical suppliers to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

Pharma Sources Insight April 2023 focuses on the following topics and more:

From the Editor

- Trends in Approval of Traditional Chinese Medicines

Brand Story

- Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic media supplier for industrial scale production

APIs

- Against Liver Cancer, Statins Help Novel Liver Cancer Drug Development

- How Africa, Asia Could Benefit from Ticagrelor’s WHO Listing

- Proposal to Have Empagliflozin API as Option for Children with Type 2 Diabetes

Pharmaceutical R & D

- Research Progress in Signaling Pathway and Related Drugs of Target GDF15

- Global Diabetes Market Outlook

Pharma in China

- Popular Products and Companies at PharmaSources.com

- The Increasing ADC+CDMO Industry Collaboration

Industry Insight

- FDA's Approval was Postponed Again, Chinese Innovative Pharmaceutical Companies Extend Their Businesses to the Middle East and North Africa

- Powered by AI, OpenAI Technology Promises a New Technological Revolution of Drug R&D

- Pharma Co-packaging Regulations

How to read the full issue?

1. Register or Log in and click Download PSI for Free below.

2. Register or Log in to show the password, copy the password and unlock the full issue.